Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Aug 27, 2022; 14(8): 1643-1651
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1643
Published online Aug 27, 2022. doi: 10.4254/wjh.v14.i8.1643
Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
Naiade Silveira Almeida, Claudineia Almeida de Souza, Carla Daltro, Rafael Silva, Manoel Sarno, Helma Pinchemel Cotrim, Programa de Pós-Graduação em Medicina e Saúde, Universidade Federal da Bahia, Salvador 40110-060, BA, Brazil
Raquel Rocha, Ana Carolina Sirelli da Cruz, Bruna dos Reis Ribeiro, Luiza Valois Vieira, Carla Daltro, Departamento de Ciência da Nutrição, Escola de Nutrição, Universidade Federal da Bahia, Salvador 40110-060, Brazil
Rafael Silva, Manoel Sarno, Caliper Clínica e Escola de Imagem, Salvador 41810-012, Brazil
Author contributions: Almeida NS, da Cruz ACS, de Souza CA, Rocha R, Ribeiro BR participation in the literature review, analysis and interpretation of data, and final writing of the manuscript; Daltro C, Cotrim HP, data analysis and interpretation, literature review and analysis, and final writing of the manuscript; Vieira LV, Silva R, Sarno M data collection; all authors provided critical contributions and approved the manuscript.
Institutional review board statement: This study was reviewed and approved by the Research Ethics Committee of the School of Nutrition of the Federal University of Bahia (Approval No. 2.443.762).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors have no conflicts of interest to declare.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at email address raquelrocha2@yahoo.com.br. Participants gave informed consent for data sharing. No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raquel Rocha, DSc, Adjunct Associate Professor, Ciência da Nutrição, Universidade Federal da Bahia, Rua Araujo Pinho, 32, Salvador 40110-060, Brazil.
Received: March 17, 2022
Peer-review started: March 17, 2022
First decision: April 28, 2022
Revised: May 11, 2022
Accepted: July 26, 2022
Article in press: July 26, 2022
Published online: August 27, 2022
Processing time: 161 Days and 22 Hours
Peer-review started: March 17, 2022
First decision: April 28, 2022
Revised: May 11, 2022
Accepted: July 26, 2022
Article in press: July 26, 2022
Published online: August 27, 2022
Processing time: 161 Days and 22 Hours
Core Tip
Core Tip: In Non-Alcoholic Fatty Liver Disease (NAFLD), sarcopenia has been associated with the presence and severity of the disease. However, the diagnostic criteria for sarcopenia are still under evaluation and undergoing constant changes. In patients with NAFLD, sarcopenia was not common, but a higher prevalence of probable sarcopenia was observed by the most current European Working Group Consensus on Sarcopenia in Older People, 2018. This increased sensitivity to the possible early stage of sarcopenia may be an opportunity for accurate and early interventions in this population, preventing the development of sarcopenia and the worse evolution of NAFLD.